APA (7th ed.) Citation

LR, S., AJ, B., WC, A., MA, A., S, B., K, B., . . . SJ, D. (2015). A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Science translational medicine, 7(302), 302ra136. https://doi.org/10.1126/scitranslmed.aac9459

Chicago Style (17th ed.) Citation

LR, Saunders, et al. "A DLL3-targeted Antibody-drug Conjugate Eradicates High-grade Pulmonary Neuroendocrine Tumor-initiating Cells in Vivo." Science Translational Medicine 7, no. 302 (2015): 302ra136. https://doi.org/10.1126/scitranslmed.aac9459.

MLA (9th ed.) Citation

LR, Saunders, et al. "A DLL3-targeted Antibody-drug Conjugate Eradicates High-grade Pulmonary Neuroendocrine Tumor-initiating Cells in Vivo." Science Translational Medicine, vol. 7, no. 302, 2015, p. 302ra136, https://doi.org/10.1126/scitranslmed.aac9459.